Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
about
The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary DiseaseCytokine-induced cytokine production by conventional and innate lymphoid cellsRole of the inflammasome-caspase1/11-IL-1/18 axis in cigarette smoke driven airway inflammation: an insight into the pathogenesis of COPDPulmonary-intestinal cross-talk in mucosal inflammatory diseaseImmune Dysfunction in Patients with Chronic Obstructive Pulmonary DiseaseAcute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration.Cytokine inhibition in the treatment of COPD.Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extentHuman CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary diseaseHaploinsufficiency of Hedgehog interacting protein causes increased emphysema induced by cigarette smoke through network rewiring.The role of interleukin-1 and interleukin-18 in pro-inflammatory and anti-viral responses to rhinovirus in primary bronchial epithelial cells.Down regulation of T cell receptor expression in COPD pulmonary CD8 cellsActivation-induced cell death drives profound lung CD4(+) T-cell depletion in HIV-associated chronic obstructive pulmonary disease.IL-6 receptor α defines effector memory CD8+ T cells producing Th2 cytokines and expanding in asthmaCD8⁺ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung.Plasmacytoid dendritic cells mediate the regulation of inflammatory type T cell response for optimal immunity against respiratory Chlamydia pneumoniae infection.The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteriaInhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse modelCRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patientsCigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease.NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease.Mechanisms of respiratory syncytial virus modulation of airway immune responses.Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary diseaseLung CD8+ T cells in COPD have increased expression of bacterial TLRs.Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression.At the Checkpoint: Lung CD8(+) T Cells, Respiratory Viruses, and Chronic Obstructive Pulmonary DiseaseImmune response in chronic obstructive pulmonary disease.Crucial role for CD69 in allergic inflammatory responses: CD69-Myl9 system in the pathogenesis of airway inflammation.Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox.IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD.HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.Differentially Expressed Potassium Channels Are Associated with Function of Human Effector Memory CD8+ T Cells.Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema.Cytokines in chronic respiratory diseases.A single dose of lipopolysaccharide into mice with emphysema mimics human chronic obstructive pulmonary disease exacerbation as assessed by micro-computed tomography.Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD.Roles of Myeloid and Lymphoid Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
P2860
Q26771902-057F1B29-8095-4AAD-AB69-ABD4AFB391A1Q27007655-AA54DA8A-740D-4F4C-B7F8-37D32758FFC9Q27325732-5893D7DD-C178-4A49-8D0E-B7D14AF56399Q27693862-0C8C2D7A-7423-4F0D-91F0-0B45E179FE8AQ28083093-24DE87A3-D6C1-455B-B66D-DA2674B12F5EQ30371420-0CFA85D7-52F7-439C-A4C5-F0BF3E0BABB6Q31160925-72EF251E-E4F1-43FF-8902-4A10BD13672EQ33568552-26FBA94F-A3D7-4698-82C3-8BA3898CE0BDQ33578189-E8AB12A1-9224-44DC-9BAE-D3ACB582DDFFQ33982284-9883A774-8976-4522-88C5-E56321E76822Q34466780-D7C71E94-79BA-4C4B-9929-FFC995A692D4Q34749235-697EFA21-2B79-478B-92B5-78845B63C151Q34971707-D9EA8DC1-D609-4502-A467-AEA0BD837FE4Q34987059-AF0C5CC0-3601-4282-BA5C-5D0C16EB4A2FQ34987183-F93348B5-B5F5-4222-B80E-E48CAA902A6BQ35015677-A7580FB6-5EB7-41A4-9E62-5335BB4C0C44Q35080398-64742055-623E-4D6C-B81C-503B73772998Q35118652-B1CA13FA-BCE7-44A0-868E-B4EC49BB9334Q35191277-071132C3-E652-46C9-8143-D7EF847076E1Q35457347-8E3091F5-CEEF-4C19-AC93-F27862C87AA1Q35677380-E5CD11C3-B3AE-4B2C-94FA-27A93AB14950Q35903449-62A49EA7-EAD4-444A-BB53-68894AE78461Q36203787-B8F7961A-4168-4A3F-93FD-36A2BE57313BQ36553784-2E617AAA-0ED3-4540-9A30-B37AC7207326Q36643067-49FC5EB7-5698-45A2-8502-8ECA8DAC015FQ36690891-F63B6602-43B1-4807-8661-C278948E4AABQ36778637-9A225B9C-AD12-408B-894A-CAC7639548C6Q38144104-945A3F15-F238-4F06-8E91-2C754926D6CAQ39402889-31DD4F83-6EF6-41D8-B47C-646E3D02F13AQ39457854-4CDF3802-60A3-486E-BE19-260D5857DF98Q40074926-152F5174-F49B-4C3E-B6F2-CCEFC2945F15Q40480304-5ECA178E-49A8-40A4-BBE6-717C29E1C3E0Q41097132-E37A7F55-480B-44E5-89A7-F29FE825BA6FQ41682834-B1967BF5-63E4-49BF-9944-B6A1AC4171DDQ42113962-6A529CB6-09B7-4033-8B7D-BD8E226C3AA9Q42286333-EBD86C4A-1FC6-4073-8D0A-3E6F061F7354Q46165199-18CA83D3-BB3D-4B26-B658-B60966BF778CQ48313511-60CC7647-3A81-41D5-97A4-C4EC589C93F9Q55094162-2E3CA396-F745-4705-84F9-C7943D591ACEQ55440438-F627919C-3B2C-4D1F-9649-5778C39EF5C3
P2860
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cytotoxic potential of lung CD ...... stimulation by IL-18 or IL-15.
@ast
Cytotoxic potential of lung CD ...... stimulation by IL-18 or IL-15.
@en
type
label
Cytotoxic potential of lung CD ...... stimulation by IL-18 or IL-15.
@ast
Cytotoxic potential of lung CD ...... stimulation by IL-18 or IL-15.
@en
prefLabel
Cytotoxic potential of lung CD ...... stimulation by IL-18 or IL-15.
@ast
Cytotoxic potential of lung CD ...... stimulation by IL-18 or IL-15.
@en
P2093
P2860
P356
P1476
Cytotoxic potential of lung CD ...... stimulation by IL-18 or IL-15.
@en
P2093
Catherine A Meldrum
Christi Getty
Christine M Freeman
Douglas A Arenberg
Fernando J Martinez
Jill C Todt
Joanne Sonstein
Lisa McCloskey
Lyrica X Liu
MeiLan K Han
P2860
P304
P356
10.4049/JIMMUNOL.1000006
P407
P577
2010-04-28T00:00:00Z